HIV Diagnostics Market worth $5.31 billion by 2030
The report "HIV Diagnostics Market by Product (Assay Kits & Reagents, Instrument, Software), Test Type (Rapid Test, ELISA, Western Blot, Viral Load, CD4 Test), End User (Diagnostic Laboratories, Homecare Settings, Hospital) - Global Forecast to 2030"global HIV diagnostics market is projected to reach USD 5.31 billion by 2030 from USD 3.25 billion in 2025, at a CAGR of 10.3% during the forecast period.
Browse 332 market data Tables and 50 Figures spread through 273 Pages and in-depth TOC on "HIV Diagnostics Market by Product (Assay Kits & Reagents, Instrument, Software), Test Type (Rapid Test, ELISA, Western Blot, Viral Load, CD4 Test), End User (Diagnostic Laboratories, Homecare Settings, Hospital) - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/hiv-diagnosis-market-66008285.html
The market is expanding due to the growing prevalence of HIV/AIDS, the advantages of point-of-care instruments and kits, and increased efforts to raise HIV awareness. However, factors such as the high cost of NATs, operational challenges, and a lack of skilled laboratory technicians are limiting growth. Despite these challenges, the promising potential of emerging economies and the increasing adoption of self-testing are expected to present significant opportunities for market players during the forecast period.
Government-led health initiatives and public awareness campaigns promoting early HIV testing are driving market growth. Additionally, advancements in rapid testing technology and improved accessibility to self-testing kits are enhancing patient compliance, increasing adoption rates. Despite these advancements, challenges such as the high cost of diagnostic tests and limited availability of skilled professionals may hinder market expansion. Nevertheless, the market is expected to grow steadily due to rising awareness, improved healthcare infrastructure, and the increasing demand for convenient and accurate HIV testing solutions.
In 2024, the consumables segment accounted for the largest share of the HIV diagnostics market
The HIV diagnostics market is segmented by product type into consumables, instruments, and software & services. In 2024, the consumables segment held the largest market share. This dominance, along with its high growth rate, is driven by the frequent and repetitive purchase of consumables by laboratories and hospitals, the rising prevalence of HIV/AIDS, and supportive government initiatives aimed at introducing advanced consumables.
In 2024, the confirmatory tests segment accounted for the largest share of the HIV diagnostics market.
By test type, the HIV diagnostics market is categorized into screening tests, confirmatory tests, and monitoring tests. In 2024, the monitoring tests segment accounted for the largest market share and is projected to grow at the highest CAGR. This growth is fueled by increasing awareness of HIV testing, a high volume of monitoring test samples, and the expansion of diagnostic laboratories specializing in HIV/AIDS testing. Additionally, technological advancements in monitoring test kits further contribute to the segment's rapid growth.
The diagnostic laboratories accounted for the largest share of the HIV diagnostics market, by enduser segment, in 2024
Based on end users, the HIV diagnostics market is categorized into diagnostic laboratories, hospitals, blood banks, home care settings, and other end users. In 2024, the diagnostic laboratories segment held the largest market share. This dominance can be attributed to the rising prevalence of HIV/AIDS, the growing number of diagnostic laboratories, the increasing volume of sample testing, and advancements in point-of-care (POC) instruments.
North America is the largest regional market for HIV diagnostics market
The HIV diagnostics market is divided into six regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries. North America leads the global market and is expected to maintain its dominance throughout the forecast period. Factors such as the rising prevalence of HIV/AIDS, advancements in PoC instruments and kits, increasing awareness about HIV/AIDS, and increasing blood transfusion and blood donations are driving the growth of the HIV diagnostics market in North America.The major market players involved in this market are Abbott (US), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), and Grifols, S.A. (Spain), Bio-Rad Laboratories (US), F. Hoffmann-La Roche Ltd. (Switzerland), bioMérieux SA (France), Hologic, Inc. (US), QIAGEN (Germany), Becton, Dickinson, and Company (US), Trinity Biotech (Ireland), OraSure Technologies (US), BioSynex SA (Chembio Diagnostics) (France), Wondfo (China), Getein Biotech Inc. (China), Meril Diagnostics (India), AccuBioTech (China), BioLytical Laboratories Inc. (Canada), BioLab Diagnostics (India), Alpine Biomedicals Pvt. Ltd (India), Molbio Diagnostics (India), Fortress Diagnostics (UK), AdvaCare Pharma (US), Adaltis s.r.l (Italy) among others.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the HIV Diagnostics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
